Click to Share

Filter News
Show All Results
News By Country
News By Tag
Vaccine Remove

December 2019

Public Company News

Business Press Releases

Vaccine Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

By DPI Research
DPI Research has recently updated its massive report catalogue by adding a fresh study titled "Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential".
By Valuates Reports
Global Vaccine for Non-infectious Meningitis Market Insights, Forecast to 2025
By Orion Market Research
Global Animal Vaccine Market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2018-2023
By Biosceptre International Limited
Biosceptre has initiated its Phase I clinical trial of the peptide vaccine BIL06v, with the first patient treated at the initial trial site on 16th of August 2018.
By Gold Law Firm, LLC.
Gold law Firm, LLC., recently filed a vaccine petition for a Massachusetts woman who had a severe vaccine injury reaction to the Flu Vaccine resulting in SIRVA, Shoulder Injury Related to Vaccine Administration.
By Biosceptre International
The proposed Phase I clinical trial for BIL06v (anti-cancer vaccine) was granted conditional approval by the Bellberry Ethics committee on 21st February 2018.
By DPI Research
DPI Research adds " Flu Vaccine Market Outlook 2024: United States Opportunity and Demand Analysis, Market Forecast 2024 " to its offering
Biosceptre has received over £8M into its series A raise which will be used to resource the next stage of the companies' development; progression into the clinic of Biosceptre's first systemic products against novel oncology target nfP2X7.

Page updated every 10 minutes

Like PRLog?
Click to Share